Trevi Therapeutics, Inc. (TRVI) › Shares OutstandingTrevi Therapeutics, Inc. (TRVI) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2018: 438.6K2019: 17.83M2020: 18.55M2021: 28.51M2022: 59.94M2023: 68.28M2024: 93.60M2025: 128.31M128.31M2018Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025128.31M+37.1%202493.60M+37.1%202368.28M+13.9%202259.94M+110.3%202128.51M+53.7%202018.55M+4.0%201917.83M+3966.2%2018438.6K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share